Company Overview of Talisman Therapeutics Ltd
Talisman Therapeutics Ltd engages in the research and development of human stem cells for the treatment of dementia. The company focuses on the discovery of treatments for Alzheimer's disease. It serves large pharmaceutical companies, small biotech businesses, and universities. The company was incorporated in 2013 and is based in Cambridge, United Kingdom.
Jonas Webb Building
Babraham Research Campus
Cambridge, CB22 3AT
Founded in 2013
44 1223 804 070
Key Executives for Talisman Therapeutics Ltd
Similar Private Companies By Industry
|Achilles Therapeutics Ltd.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Talisman Therapeutics Ltd, please visit www.talisman-therapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.